KD Logo

Investing in Crinetics Pharmaceuticals Inc (CRNX) Is Getting More Attractive

Crinetics Pharmaceuticals Inc’s recently made public that its Chief Med and Dev Officer Pizzuti Dana unloaded Company’s shares for reported $0.65 million on Jul 03 ’24. In the deal valued at $44.87 per share,14,375 shares were sold. As a result of this transaction, Pizzuti Dana now holds 28,507 shares worth roughly $1.25 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Wilson Marc sold 32,129 shares, generating $1,401,146 in total proceeds. Upon selling the shares at $43.61, the CFO now owns 111,092 shares.

Before that, Knight Jeff E. sold 956 shares. Crinetics Pharmaceuticals Inc shares valued at $42,427 were divested by the Chief Operating Officer at a price of $44.38 per share. As a result of the transaction, Knight Jeff E. now holds 52,580 shares, worth roughly $2.3 million.

Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.

Price Performance Review of CRNX

On Friday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock fall -0.84% to $43.83. Over the last five days, the stock has gained 0.83%. Crinetics Pharmaceuticals Inc shares have risen nearly 23.19% since the year began. Nevertheless, the stocks have risen 143.50% over the past one year. While a 52-week high of $53.70 was reached on 05/22/24, a 52-week low of $15.76 was recorded on 01/05/24. SMA at 50 days reached $46.36, while 200 days put it at $38.35. A total of 0.57 million shares were traded, compared to the trading of 0.33 million shares in the previous session.

Levels Of Support And Resistance For CRNX Stock

The 24-hour chart illustrates a support level at 43.54, which if violated will result in even more drops to 43.25. On the upside, there is a resistance level at 44.29. A further resistance level may holdings at 44.75. The Relative Strength Index (RSI) on the 14-day chart is 44.32, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 54.84%. Stochastics%K at 44.39% indicates the stock is a holding.

Most Popular